3-(4-Bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione, 97.0%, 250mg

N-(3-Bromo-4-methylphenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine, 98%, 25mg

1-(4-tert-butylbenzoyl)piperidine-4-carboxylic acid, 95.0%, 50g

(2E)-3-(2-chlorophenyl)-1-(3,4-dichlorophenyl)prop-2-en-1-one, 95.0%, 10g

2,4,6-Trimethylpyridine>98.0%(GC)(T)100mL

Naphthalene-1-thiol>98.0%(GC)(T)1g

Methyl adamantane-1-carboxylate, 95.0%, 25g

ROTI®Pol TaqUltra, 200 µl, 5 x 40 µl

1-[(5-Bromo-2-methyl-4-methylsulfonyl)phenyl]piperidine-4-carboxamide, 1g

2,2'-(Ethane-1,2-diylbis(sulfanediyl))diethanol, 95.0%, 5g

(R)-3-Boc-aminocyclohexanone, 98%, 100mg

1H-PYRROLO[3,2-B]PYRIDINE-2-CARBOXYLIC ACID, 7-CHLORO-3-METHYL-, ETHYL ESTER, 95.0%, 250mg

3-(1H-Pyrrol-2-yl)propanoic acid, 98.0%, 10g